Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?
利妥昔单抗在多发性硬化症中的疗效持续时间超过 B 细胞再生:是时候重新考虑给药方案了吗?
期刊:Neurology-Neuroimmunology & Neuroinflammation
影响因子:7.5
doi:10.1212/NXI.0000000000200152
Claverie, Roxane; Perriguey, Marine; Rico, Audrey; Boutiere, Clemence; Demortiere, Sarah; Durozard, Pierre; Hilezian, Frederic; Dubrou, Clea; Vely, Frederic; Pelletier, Jean; Audoin, Bertrand; Maarouf, Adil